Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by shangqian wang
Mp78-10 the Influence of Genetic Variants on Clinical Outcomes and Toxic Effects in Patients With Advanced Renal Cell Carcinoma Treated With Sorafenib: A Multi-Center Research
Journal of Urology
Urology
Related publications
Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated With Sorafenib
Cancer Research
Cancer Research
Oncology
Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma
Hepatoma Research
Mp03-13 Clinical Outcomes in Patients With Metastatic Papillary Renal Cell Carcinoma: A Japanese Multi-Institutional Study
Journal of Urology
Urology
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Efficacy of Cryoablation Combined With Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
International Journal of Hyperthermia
Medicine
Cancer Research
Radiological
Physiology
Ultrasound Technology
Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes
Journal of Medical Cases
Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Journal of Hepatocellular Carcinoma
Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Genetic Variants of EGF and VEGF Predict Prognosis of Patients With Advanced Esophageal Squamous Cell Carcinoma
PLoS ONE
Multidisciplinary
